Home/Filings/4/0001209191-21-020594
4//SEC Filing

Shaffer James P 4

Accession 0001209191-21-020594

CIK 0001305253other

Filed

Mar 14, 8:00 PM ET

Accepted

Mar 15, 7:41 PM ET

Size

7.4 KB

Accession

0001209191-21-020594

Insider Transaction Report

Form 4
Period: 2021-03-12
Shaffer James P
Chief Business Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-03-12+71,25071,250 total
    Exercise: $9.99Exp: 2031-03-11Common Stock (71,250 underlying)
  • Award

    Common Stock

    2021-03-12+11,87529,296 total
Footnotes (3)
  • [F1]Represents shares underlying Restricted Stock Units award that will vest in three equal annual installments measured from March 12, 2021.
  • [F2]Includes 1,500 shares acquired by the Reporting Person under the Issuer's Employee Stock Purchase Plan on March 5, 2021.
  • [F3]The option vests in equal monthly installments over 48 months measured from March 12, 2021 subject to Reporting Person's continuous service status as of each such date.

Issuer

Eiger BioPharmaceuticals, Inc.

CIK 0001305253

Entity typeother

Related Parties

1
  • filerCIK 0001488919

Filing Metadata

Form type
4
Filed
Mar 14, 8:00 PM ET
Accepted
Mar 15, 7:41 PM ET
Size
7.4 KB